Whither osteoarthritis biomarkers?

Osteoarthritis and Cartilage

Volumn 17, Issue 4, 2009, Pages 419-422

  Felson, D T ^a   Lohmander, L S ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Biomarker; Epidemiology; Osteoarthritis

Indexed keywords

BIOLOGICAL MARKER; RISEDRONIC ACID;

ARTICULAR CARTILAGE; BIOCHEMISTRY; BONE DENSITY; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; EDITORIAL; HUMAN; JOINT RADIOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RELIABILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDITY; BLOOD; REPRODUCIBILITY; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; HUMANS; OSTEOARTHRITIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 61549126962     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.02.004     Document Type: Editorial

References (15)

1. Bauer D.C., Hunter D.J., Abramson S.B., Attur M., Corr M., Felson D., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 14 8 (2006 Aug) 723-727
2. Kraus V.B. Do biochemical markers have a role in osteoarthritis diagnosis and treatment?. Best Practice and Research Clinical Rheumatology 20 1 (2006) 69-80
3. Lohmander L.S., and Eyre D. Biochemical markers as surrogate endpoints of joint disease. In: Reid D.M., and Miller C.G. (Eds). Clinical Trials in Rheumatoid Arthritis and Osteoarthritis (2008), Springer Verlag;, London 249-274
4. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints; preferred definitions and conceptual framework. Clinical Pharmacological Therapy 69 (2001) 89-95
5. Fleming T.R., and DeMets D.L. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 125 7 (1996) 605-613
6. Hunter D.J., Li J., Lavalley M., Bauer D.C., Nevitt M., DeGroot J., et al. Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther 9 5 (2007) R108
7. Bingham III C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54 11 (2006 Nov) 3494-3507
8. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Clin Chem 49 (2003) 1-6
9. Simkin P.A. Synovial physiology in the context of osteoarthritis. In: Brandt K., Doherty M., and Lohmander L.S. (Eds). Osteoarthritis. 2nd edn. (2003), Oxford University Press, Oxford 155-161
10. Jordan J.M., Luta G., Stabler T., Renner J.B., Dragomir A.D., and Vilim V. Ethnic and sex differences in serum levels in cartilage oligomeric matrix protein. Arthritis Rheum 48 3 (2003) 675-681
11. Amin S., Lavalley M.P., Guermazi A., Grigoryan M., Hunter D.J., Clancy M., et al. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum 52 10 (2005 Oct) 3152-3159
12. Christgau S., Garnero P., Fledelius C., Moniz C., Ensig M., Ginetys E., et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29 (2001) 209-215
13. Garnero P. Use of biochemical markers to study and follow patients with osteoarthritis. Curr Rheumatol Rep 8 (2006) 37-44
14. Hwang J., Bae W.C., Shieu W., Lewis C.W., Bugbee W.D., and Sah R.L. Increased hydraulic conductance of human articular cartilage and subchondral bone plate with progression of osteoarthritis. Arthritis Rheum 58 12 (2008) 3831-3842
15. Lohmander L.S. Can treatment with risedronate benefit patients with knee osteoarthritis?. Nature Clin Pract Rheumatol 3 (2007) 198-199